Detailed information for compound 455645

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 355.341 | Formula: C18H15F2N5O
  • H donors: 1 H acceptors: 4 LogP: 1.78 Rotable bonds: 5
    Rule of 5 violations (Lipinski): 1
  • SMILES: Fc1ccc(c(c1)F)C(Cn1ccc2c1nccc2)(Cn1cncn1)O
  • InChi: 1S/C18H15F2N5O/c19-14-3-4-15(16(20)8-14)18(26,10-25-12-21-11-23-25)9-24-7-5-13-2-1-6-22-17(13)24/h1-8,11-12,26H,9-10H2
  • InChiKey: HRTVXCGNJKVFFZ-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Plasmodium vivax inosine-5'-monophosphate dehydrogenase, putative 0.2348 0.9169 0.5
Trichomonas vaginalis peptide N-glycanase, putative 0.0712 0 0.5
Trypanosoma cruzi GMP reductase 0.2496 1 0.5
Brugia malayi inosine-5'-monophosphate dehydrogenase 0.1037 0.1825 0.1825
Trypanosoma cruzi inosine-5'-monophosphate dehydrogenase, putative 0.2496 1 0.5
Mycobacterium ulcerans inosine 5-monophosphate dehydrogenase 0.1186 0.2656 0.2656
Wolbachia endosymbiont of Brugia malayi IMP dehydrogenase 0.2496 1 0.5
Giardia lamblia Transglutaminase/protease, putative 0.0712 0 0.5
Trypanosoma cruzi inosine-5'-monophosphate dehydrogenase, putative 0.2496 1 0.5
Schistosoma mansoni inosine-5-monophosphate dehydrogenase 0.2496 1 1
Brugia malayi inosine-5'-monophosphate dehydrogenase 0.1037 0.1825 0.1825
Trypanosoma brucei inosine-5'-monophosphate dehydrogenase 0.2496 1 0.5
Loa Loa (eye worm) IMP dehydrogenase 1 0.2496 1 1
Echinococcus multilocularis inosine 5' monophosphate dehydrogenase 2 0.2496 1 1
Trypanosoma cruzi inosine-5'-monophosphate dehydrogenase, putative 0.2496 1 0.5
Toxoplasma gondii IMP dehydrogenas 0.2496 1 0.5
Trypanosoma brucei GMP reductase 0.2496 1 0.5
Leishmania major inosine-5-monophosphate dehydrogenase 0.2496 1 0.5
Trypanosoma cruzi GMP reductase 0.2496 1 0.5
Onchocerca volvulus Putative GMP reductase 0.1037 0.1825 1
Leishmania major guanosine monophosphate reductase 0.2496 1 0.5
Mycobacterium ulcerans inosine 5'-monophosphate dehydrogenase 0.2496 1 1
Mycobacterium ulcerans inosine 5-monophosphate dehydrogenase 0.2348 0.9169 0.9169
Mycobacterium tuberculosis Probable inosine-5'-monophosphate dehydrogenase GuaB2 (imp dehydrogenase) (inosinic acid dehydrogenase) (inosinate dehydrogenase 0.2496 1 1
Mycobacterium leprae Probable inosine-5'-monophosphate dehydrogenase GuaB3 (IMP dehydrogenase 2) (inosinic acid dehydrogenase) (inosinate dehydrogena 0.1311 0.3356 0.3356
Giardia lamblia Hypothetical protein 0.0712 0 0.5
Mycobacterium leprae Probable inosine-5'-monophosphate dehydrogenase GuaB2 (IMP dehydrogenase) (IMPDH) (IMPD) 0.2496 1 1
Mycobacterium tuberculosis Probable inosine-5'-monophosphate dehydrogenase GuaB3 (imp dehydrogenase) (inosinic acid dehydrogenase) (inosinate dehydrogenase 0.1311 0.3356 0.3356
Brugia malayi GMP reductase 0.1037 0.1825 0.1825
Plasmodium falciparum inosine-5'-monophosphate dehydrogenase 0.2348 0.9169 0.5
Echinococcus granulosus inosine 5' monophosphate dehydrogenase 2 0.2496 1 1
Mycobacterium leprae PROBABLE INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE GUAB1(IMP DEHYDROGENASE) (IMPDH) (IMPD) 0.1186 0.2656 0.2656

Activities

Activity type Activity value Assay description Source Reference
MIC (functional) = 0.007 ug ml-1 Antifungal activity against Candida albicans CA980001 by alamar blue assay ChEMBL. 17482460
MIC (functional) = 21 ug ml-1 Antifungal activity against Aspergillus fumigatus AF980003 by alamar blue assay ChEMBL. 17482460

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.